Page last updated: 2024-09-05

1,4,7-triazacyclononane and catechol

1,4,7-triazacyclononane has been researched along with catechol in 1 studies

Compound Research Comparison

Studies
(1,4,7-triazacyclononane)
Trials
(1,4,7-triazacyclononane)
Recent Studies (post-2010)
(1,4,7-triazacyclononane)
Studies
(catechol)
Trials
(catechol)
Recent Studies (post-2010) (catechol)
760392,1755867

Protein Interaction Comparison

ProteinTaxonomy1,4,7-triazacyclononane (IC50)catechol (IC50)
Carbonic anhydrase 1Homo sapiens (human)5.79
Carbonic anhydrase 2Homo sapiens (human)5.79
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)0.868
Carbonic anhydrase 6Homo sapiens (human)5.79
Glutaminyl-peptide cyclotransferaseHomo sapiens (human)5
Carbonic anhydrase 3Bos taurus (cattle)5.79

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane and catechol

ArticleYear
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
    Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

    Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc

2011